MacroGenics (MGNX) Insider Trading & Ownership $3.24 +0.03 (+0.93%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MacroGenics (NASDAQ:MGNX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.63 M Get MGNX Insider Trade Alerts Want to know when executives and insiders are buying or selling MacroGenics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MGNX Insider Buying and Selling by Quarter Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. MacroGenics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/4/2024Jeffrey Stuart PetersVPSell51,395$15.55$799,192.25 2/26/2024Jeffrey Stuart PetersVPSell16,124$17.22$277,655.28 2/1/2024Ezio BonviniSVPSell13,316$15.00$199,740.00 1/19/2024Ezio BonviniSVPSell13,316$12.00$159,792.00 12/20/2023Ezio BonviniSVPSell18,880$10.08$190,310.40 (Data available from 1/1/2013 forward) MGNX Insider Trading Activity - Frequently Asked Questions Who is on MacroGenics's Insider Roster? The list of insiders at MacroGenics includes Edward Hurwitz, Ezio Bonvini, James Karrels, Jeffrey Stuart Peters, and Target N V Biotech. Learn more on insiders at MGNX. What percentage of MacroGenics stock is owned by insiders? 11.30% of MacroGenics stock is owned by insiders. Learn more on MGNX's insider holdings. Which MacroGenics insiders have been buying company stock? The following insiders have purchased MGNX shares in the last 24 months: Edward Hurwitz ($73,650.00), and Target N V Biotech ($7,349,000.00). How much insider buying is happening at MacroGenics? Insiders have purchased a total of 1,415,000 MGNX shares in the last 24 months for a total of $7,422,650.00 bought. Which MacroGenics insiders have been selling company stock? The following insiders have sold MGNX shares in the last 24 months: Ezio Bonvini ($549,842.40), and Jeffrey Stuart Peters ($1,109,240.69). How much insider selling is happening at MacroGenics? Insiders have sold a total of 118,403 MacroGenics shares in the last 24 months for a total of $1,659,083.09 sold. MacroGenics Key ExecutivesDr. Scott Koenig M.D. (Age 72)Ph.D., President, CEO & Director Compensation: $1.2MMr. James Karrels (Age 57)Senior VP, CFO & Corporate Secretary Compensation: $693.31kDr. Stephen L. Eck M.D. (Age 69)Ph.D., Senior VP of Clinical Development & Chief Medical Officer Compensation: $766.85kMr. Eric Blasius Risser (Age 51)Chief Operating Officer Compensation: $651.36kDr. Thomas M. Spitznagel Ph.D. (Age 57)Senior Vice President of Technical Operations Compensation: $550.97kDr. Ezio Bonvini M.D. (Age 70)Senior VP of Research & Chief Scientific Officer Compensation: $612.21kMr. Jeffrey Stuart Peters (Age 53)Senior VP, General Counsel & Corporate Compliance Officer Ms. Lynn Cilinski (Age 66)VP, Controller & Treasurer More Insider Trading Tools from MarketBeat Related Companies Puma Biotechnology Insider Selling Repare Therapeutics Insider Selling Cronos Group Insider Selling Pliant Therapeutics Insider Selling Kura Oncology Insider Selling Tyra Biosciences Insider Selling Prothena Insider Selling Relay Therapeutics Insider Selling Anavex Life Sciences Insider Selling Replimune Group Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:MGNX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MacroGenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MacroGenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
